Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on SalesTimes Interest Earned

GT Biopharma (GTBP) Asset Utilization Ratio (2016 - 2020)

GT Biopharma (GTBP) has disclosed Asset Utilization Ratio for 6 consecutive years, with 3.66 as the latest value for Q3 2020.

  • On a quarterly basis, Asset Utilization Ratio rose 3089.65% to 3.66 in Q3 2020 year-over-year; TTM through Sep 2020 was 3.66, a 3089.65% increase, with the full-year FY2011 number at 0.17, changed N/A from a year prior.
  • Asset Utilization Ratio was 3.66 for Q3 2020 at GT Biopharma, down from 5.33 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 9.09 in Q1 2020 to a low of 0.15 in Q1 2016.
  • A 4-year average of 2.24 and a median of 0.04 in 2019 define the central range for Asset Utilization Ratio.
  • Peak YoY movement for Asset Utilization Ratio: plummeted 1433.63% in 2019, then soared 21185.2% in 2020.
  • GT Biopharma's Asset Utilization Ratio stood at 0.1 in 2016, then soared by 92.29% to 0.01 in 2018, then surged by 89819.62% to 7.16 in 2019, then crashed by 48.9% to 3.66 in 2020.
  • Per Business Quant, the three most recent readings for GTBP's Asset Utilization Ratio are 3.66 (Q3 2020), 5.33 (Q2 2020), and 9.09 (Q1 2020).